ACLS Flashcards

(36 cards)

1
Q

types of rhythms in cardiac arrest

A

pulseless electrical activity (PEA), asystole, ventricle fibrillation (VF), pulseless ventricular tachycardia (pVT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

non-shockable rhythms

A

asystole and PEA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

shockable rhythms

A

pVT and VF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PEA and asystole treatment

A
  1. EPInephrine ASAP
  2. CPR 2 min cycles
    epi every 3-5 min (every pulse check)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pVT and VF treatment

A
  1. shock
  2. cpr 2 min cycle
    epi every 3-5 min (every pulse check)
    repeat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

routes of admin pearl

A

Intraosseous (IO) equivalent to IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

endotracheal tube (ETT) medications

A

NAVEL
-Naloxone
-Atropine
-Vasopressin
-Epinephrine
-Lidocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

NAVEL dosing

A

2-2.5x IV dose, repeat the dose when IV access is secured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

vasoactive agents goal

A

-increase BP and CO
-induce vasoconstriction and increase systemic vascular resistance, mean arterial pressure (MAP), and organ blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

vasoactive agents

A

epinephrine and vasopressin (but removed from ACLS guidelines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

epinephrine indications

A

VF, pVT, PEA, asystole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

epinephrine dosing and formulation

A

formulation: 1mg/10mL syringes
dosing: 1mg IVP/IO q3-5min
(high dose not shown improvement over standard dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

epinephrine after ROSC achieved and bradyarrythmias

A

start drip at 2-10 mcg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

epinephrine side effects

A

tachycardia, hypertension, tissue necrosis if extravasation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

anti arrhythmic agents

A

amiodarone, lidocaine, magnesium (torsades only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

antiarrythmic use

A

VF or pVT unresponsive to defibrillation

17
Q

amiodarone formulation and dosing

A

formulation: 150mg/3mL vials
dosing: 300mg IV bolus
redose: 150mg IV bolus

18
Q

amiodarone after ROSC achieved

A

bolus: 150mg IV over 10min followed by 20mL NS flush
maintenance: 1mg/min for 6 hrs, then 0.5mg/min over 18hrs

19
Q

amiodarone side effects

A

hypotension and bradycardia

20
Q

lidocaine formulations and dosing

A

formulation: 2% 100mg/5mL syringe
dosing: 1-1.5mg/kg IV/IO
redose: 0.5-0.75 mg/kg q5-10min
stable VT: 0.5-0.75 mg/kg IV

21
Q

lidocaine after ROSC achieved

A

continuous infusion of 1-4 mg/min

22
Q

lidocaine side effects

A

hypotension, bradycardia, heart block

23
Q

magnesium (torsades) formulation and dosing

A

formulation: 50% 1g/2mL vial
dosing: 1-2g bolus flushed with 10-20mL NS

24
Q

reversible causes of cardiac arrest (H&T): H’s

A

hypovolemia, hypoxia, hydrogen ions, hyperkalemia, hypothermia

25
reversible causes of cardiac arrest (H&T): T's
toxins, cardiac tamponade, tension pneumothorax, coronary thrombosis, pulmonary thrombosis
26
hypovolemia
low fluids: blood loss, dehydration, urine, third spacing
27
hydrogen ions (acidosis)
severe metabolic acidosis caused by increased H+ ions in the blood -bicarb not recommended
28
hypoxia and hypothermia
hypoxia: 100% oxygen through mask hypothermia: heat
29
hyperkalemia
K > 5.5mEq/L
30
calcium chloride for hyperkalemia treatment
formulation: 10% 1g/10mL syringe dose: 1g IV
31
calcium chloride indications
hyperkalemia, hypocalcemia, CCB/BB overdose
32
sodium bicarbonate for hyperkalemia treatment
formulation: 8.4% 50mEq/50mL syringe dose: 1 mEq/kg IV (1 amp) *avoid co-admin with calcium
33
sodium bicarbonate indications
hyperkalemia and TCA overdose
34
naloxone use and dosing
indication: opioid overdose formulation: 0.4mg/mL vial dosing: 0.4mg IV (can repeat)
35
thrombosis (PE and MI)
PE: thrombolytic (alteplase and tenecteplase) MI: PCI
36
pharmacist responsibilities
draw up correct doses, recommend appropriate doses/meds, keep track of timing of epi, drug prep, documentation